Reversal of Obesity- and Diet-Induced Insulin Resistance with Salicylates or Targeted Disruption of Ikkβ
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
We show that high doses of salicylates reverse hyperglycemia, hyperinsulinemia, and dyslipidemia in obese rodents by sensitizing insulin signaling. Activation or overexpression of the IκB kinase β (IKKβ) attenuated insulin signaling in cultured cells, whereas IKKβ inhibition reversed insulin resistance. Thus, IKKβ, rather than the cyclooxygenases, appears to be the relevant molecular target. Heterozygous deletion ( Ikkβ +/− ) protected against the development of insulin resistance during high-fat feeding and in obese Lep ob/ob mice. These findings implicate an inflammatory process in the pathogenesis of insulin resistance in obesity and type 2 diabetes mellitus and identify the IKKβ pathway as a target for insulin sensitization.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In contrast, inhibition or inactivation of JNK (18,26) or IKK (22,24,25,27) improves insulin sensitivity in various models of insulin resistance in association with reduced inhibitory serine phosphorylation of IRS-1 (18).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [22]
In the citing paper
“Along these lines, numerous insulin-resistant states (e.g., obesity, type 2 diabetes, and lipid/heparin infusion) are associated with increased activation of JNK (18,21) and/or IKK (21)(22)(23)(24)(25) in parallel with inhibitory serine phosphorylation of IRS-1 (18,21).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [22]
In the citing paper
“Accordingly, KO or inhibition of JNK1 or IKKβ prevents insulin resistance in cell and mouse models (18,22,24,25,87) as well as human models (27) of insulin resistance.”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [22]
In the citing paper
“JNK (18,21) and IKK (22,25) signaling are upregulated and activated in insulin-resistant human and rodent skeletal muscle.”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [22]
Citations
Cites
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Festa, A., D’Agostino, R., Howard, G., Mykkänen, L., Tracy, R. P., & Haffner, S. M. (2000) · Circulation · doi:10.1161/01.cir.102.1.42 · Cited by 2,358
A cytokine-responsive IκB kinase that activates the transcription factor NF-κB
DiDonato, J. A., Hayakawa, M., Rothwarf, D. M., Zandi, E., & Karin, M. (1997) · Nature · doi:10.1038/41493 · Cited by 2,125
Self-citationZandi, E., Rothwarf, D. M., Delhase, M., Hayakawa, M., & Karin, M. (1997) · Cell · doi:10.1016/s0092-8674(00)80406-7 · Cited by 1,812
Self-citationInhibition of NF-κB by Sodium Salicylate and Aspirin
Kopp, E., & Ghosh, S. (1994) · Science · doi:10.1126/science.8052854 · Cited by 1,753
The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β
Yin, M.-J., Yamamoto, Y., & Gaynor, R. B. (1998) · Nature · doi:10.1038/23948 · Cited by 1,590
Griffin, M. E., Marcucci, M. J., Cline, G. W., Bell, K., Barucci, N., Lee, D., Goodyear, L. J., Kraegen, E. W., White, M. F., & Shulman, G. I. (1999) · Diabetes · doi:10.2337/diabetes.48.6.1270 · Cited by 1,267
Is Type II diabetes mellitus a disease of the innate immune system?
Pickup, J. C., & Crook, M. A. (1998) · Diabetologia · doi:10.1007/s001250051058 · Cited by 1,041
Severe Liver Degeneration in Mice Lacking the IκB Kinase 2 Gene
Li, Q., Antwerp, D. V., Mercurio, F., Lee, K.-F., & Verma, I. M. (1999) · Science · doi:10.1126/science.284.5412.321 · Cited by 963
The IκB kinase (IKK) and NF-κB: key elements of proinflammatory signalling
Karin, M., & Delhase, M. (2000) · Seminars in Immunology · doi:10.1006/smim.2000.0210 · Cited by 955
Self-citation
Research works printed but not linked: 2
- Ebstein W., Berl. Klin. Wochnschr. 13, 337 (1876).
- Supplementary Web material is available on Science Online at www.sciencemag.org/cgi/content/full/293/5535/1673/DC1.
Cited by
Items 601–700 of 999
Treatment of insulin resistance in diabetes mellitus
Lebovitz, H. E., & Banerji, M. A. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.02.051 · Cited by 102
Morris, D. L., Cho, K. W., Zhou, Y., & Rui, L. (2009) · Diabetes · doi:10.2337/db08-1388 · Cited by 93
Coll, T., Álvarez-Guardia, D., Barroso, E., Gómez-Foix, A. M., Palomer, X., Laguna, J. C., & Vázquez-Carrera, M. (2010) · Endocrinology · doi:10.1210/en.2009-1211 · Cited by 90
Vinayagamoorthi, R., Bobby, Z., & Sridhar, M. G. (2008) · Journal of Endocrinology · doi:10.1677/joe-08-0061 · Cited by 104
“…tolerance tests in male Wistar rats At the end of the 9-week experimental period, i.p. glucose and insulin tolerance tests were performed as described by Yuan et al. (2001). i.p. Glucose tolerance test was performed in overnight fasted rats after i.p. injection of glucose (2.0 g/kg body weight).”
MethodInfluentialTantiwong, P., Shanmugasundaram, K., Monroy, A., Ghosh, S., Li, M., DeFronzo, R. A., Cersosimo, E., Sriwijitkamol, A., Mohan, S., & Musi, N. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00776.2009 · Cited by 91
Obesity, Insulin Resistance, and Renal Function
Knight, S. F., & Imig, J. D. (2007) · Microcirculation · doi:10.1080/10739680701283018 · Cited by 97
Maithilikarpagaselvi, N., Sridhar, M. G., Swaminathan, R. P., & Bobby, Z. (2015) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2015.12.012 · Cited by 104
Anti-inflammatory actions of (−)-epicatechin in the adipose tissue of obese mice
Bettaieb, A., Cremonini, E., Kang, H., Kang, J., Haj, F. G., & Oteiza, P. I. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.08.044 · Cited by 97
Liver innate immune cells and insulin resistance: the multiple facets of Kupffer cells
Jager, J., Aparicio‐Vergara, M., & Aouadi, M. (2016) · Journal of Internal Medicine · doi:10.1111/joim.12483 · Cited by 90
Nutrition Regulates Innate Immunity in Health and Disease
Nobs, S. P., Zmora, N., & Elinav, E. (2020) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-120919-094440 · Cited by 102
“As such, salicylates alleviated hyperglycemia, hyperinsulinemia, and dyslipidemia in genetically obese rodents by improving insulin signaling (226), treatment with a neutralizing anti-mouse Notch ligand Delta-like 4 antibody ameliorated the development of atherosclerosis, insulin resistance, and fat accumulation in mi…”
BackgroundKim, J. K., Fillmore, J. J., Gavrilova, O., Chao, L., Higashimori, T., Choi, H., Kim, H.-J., Yu, C., Chen, Y., Qu, X., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.6.1311 · Cited by 90
Oh, D. Y., & Lagakos, W. (2011) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e3283479230 · Cited by 100
Metabolic Health, Insulin, and Breast Cancer: Why Oncologists Should Care About Insulin
Yee, L. D., Mortimer, J. E., Natarajan, R. D., Dietze, E. C., & Seewaldt, V. L. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00058 · Cited by 113
Peroxisome Proliferators‐Activated Receptor (PPAR) Modulators and Metabolic Disorders
Cho, M.-C., Lee, K., Paik, S.-G., & Yoon, D.-Y. (2008) · PPAR Research · doi:10.1155/2008/679137 · Cited by 89
“In addition, high doses of IKKβ inhibitors such as aspirin and salicylate reverse insulin resistance by sensitizing insulin signaling in obese rodents [25].”
BackgroundPTEN and SHIP2 phosphoinositide phosphatases as negative regulators of insulin signalling
Vinciguerra, M., & Foti, M. (2006) · Archives of Physiology and Biochemistry · doi:10.1080/13813450600711359 · Cited by 89
“In this respect, mouse models knock-out for IKKb, JNK or S6k1 are protected against obesity- and diet-induced insulin resistance (Yuan et al., 2001; Hirosumi et al., 2002; Um et al., 2004), thus suggesting that inhibition of these Ser/Thr protein kinases may increase systemic insulin sensitivity…”
BackgroundKuo, L.-H., Tsai, P.-J., Jiang, M.-Z., CHUANG, Y.-M., Yu, L., Lai, K.-T. A., & Tsai, Y.-S. (2010) · Diabetologia · doi:10.1007/s00125-010-1931-5 · Cited by 98
“Genetic or pharmacological inhibition of NF-κB pathways and cytokine neutralisation reverses insulin resistance [4, 6].”
BackgroundMarques-Vidal, P. M., Bastardot, F., von Känel, R., Paccaud, F. M., Preisig, M., Waeber, G., & Vollenweider, P. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04384.x · Cited by 103
Murdolo, G., & Smith, U. (2006) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2005.10.016 · Cited by 95
Petersen, K. F., & Shulman, G. I. (2006) · Obesity · doi:10.1038/oby.2006.280 · Cited by 87
“) may activate a serine/threonine kinase cascade (19-24), which may be initiated by protein kinase C in rodents (24) or protein kinase C ( and ) in humans (25).”
BackgroundBeraza, N., Malato, Y., Vander Borght, S., Liedtke, C., Wasmuth, H. E., Dreano, M., de Vos, R., Roskams, T., & Trautwein, C. (2008) · Gut · doi:10.1136/gut.2007.134288 · Cited by 87
Liedtke, C., & Trautwein, C. (2011) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2011.10.001 · Cited by 91
Matsuzaka, T., & Shimano, H. (2011) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2011.00111.x · Cited by 104
Ageing and metabolism: drug discovery opportunities
Curtis, R., Geesaman, B. J., & DiStefano, P. S. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1777 · Cited by 98
“Accordingly, high doses of aspirin reverse insulin resistance in obese rodents and type 2 diabetics, mediated by inhibition of IKK (inhibitor of nuclear factor-κB kinase β”
BackgroundArunachalam, S., Pichiah, P. B. T., & Achiraman, S. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.11.019 · Cited by 96
“Recently, it has been shown that anti-inflammatory drugs prevent the fat mediated insulin resistance, suggesting the involvement of inflammatory pathways in the pathogenesis of fat-induced insulin resistance [69,70].”
BackgroundInflammation and Insulin Resistance
Bloomgarden, Z. T. (2003) · Diabetes Care · doi:10.2337/diacare.26.5.1619 · Cited by 88
Kalman, J. L., Juhász, A., Bogáts, G., Babik, B., Rimanóczy, Á., Janka, Z., Penke, B., & Palotás, A. (2005) · Neurochemistry International · doi:10.1016/j.neuint.2005.10.007 · Cited by 85
Vias de Sinalização da Insulina
Carvalheira, J. B. C., Zecchin, H. G., & Saad, M. J. A. (2002) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302002000400013 · Cited by 250
Aspirin, NSAIDs, and Colorectal Cancer: Possible Involvement in an Insulin-Related Pathway
Slattery, M. L., Samowitz, W. S., Hoffman, M. D., Ne, K., Levin, T. R., & Neuhausen, S. L. (2004) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.538.13.4 · Cited by 91
“Aspirin/NSAID influence on insulin resistance appears to be independent of COX-2 inhibition, instead involving inhibition of nuclear factor-nB and InB and/or activation of peroxisome proliferator-activated receptors (49).”
BackgroundInsulin signalling in Alzheimer′s disease and diabetes: from epidemiology to molecular links
Ribe, E. M., & Lovestone, S. (2016) · Journal of Internal Medicine · doi:10.1111/joim.12534 · Cited by 84
Psychosocial stress and cardiovascular diseases
Vale, S. (2005) · Postgraduate Medical Journal · doi:10.1136/pgmj.2004.028977 · Cited by 99
AMPK: mediating the metabolic effects of salicylate-based drugs?
Steinberg, G. R., Dandapani, M., & Hardie, D. G. (2013) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2013.06.002 · Cited by 83
Yu, N., Zhu, M., Johnson, B. L., Liu, Y., Jones, R. O., & Zhao, H. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8195-y · Cited by 84
Roubíček, T., Bártlová, M., Krajickova, J., Haluzíková, D., Mráz, M., Lacinová, Z., Kudla, M., Teplan, V., & Haluzík, M. (2009) · Nutrition · doi:10.1016/j.nut.2008.12.012 · Cited by 98
“The hypothesis of an etiopathogenetic contribution of inflamed fat to the development of insulin resistance/atherosclerosis was further supported by studies demonstrating that partial inhibition of inflammation in fat by transgenic [26] or pharmacologic manipulations improved insulin sensitivity and delayed the progre…”
Obesity as a premature aging phenotype — implications for sarcopenic obesity
Nunan, E. L., Wright, C. L., Semola, O. A., Subramanian, M., Balasubramanian, P., Lovern, P. C., Fancher, I. S., & Butcher, J. T. (2022) · GeroScience · doi:10.1007/s11357-022-00567-7 · Cited by 91
Mitochondrial dysfunction and type 2 diabetes
Parish, R., & Petersen, K. F. (2005) · Current Diabetes Reports · doi:10.1007/s11892-005-0006-3 · Cited by 96
Stadler, K., Bonini, M. G., Dallas, S., Jiang, J., Radí, R., Mason, R. P., & Kadiiska, M. B. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.06.023 · Cited by 88
“It is noteworthy that there is also abundant evidence indicating that iNOS mediates insulin resistance where inflammatory processes are involved [57,58].”
BackgroundO-GlcNAcylation and Inflammation: A Vast Territory to Explore
Baudoin, L., & Issad, T. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00235 · Cited by 98
Vick, M. M., Murphy, B. A., Sessions, D. R., Reedy, S. E., Kennedy, E. L., Horohov, D. W., Cook, R. F., & Fitzgerald, B. P. (2008) · American Journal of Veterinary Research · doi:10.2460/ajvr.69.1.130 · Cited by 95
Zhang, J., Zhang, R., Li, W., Ma, X., Qiu, F., & Sun, C. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.85158 · Cited by 95
“Collectively, inhibition of IKKβ by salicylate or celastrol (26) decreased insulin resistance and lipid abnormalities and increased the adiponectin level to attenuate the adiposity [108, 109].”
Slattery, M. L., & Fitzpatrick, F. A. (2009) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-08-0191 · Cited by 86
Use of cell permeable NBD peptides for suppression of inflammation
Strickland, I., & Ghosh, S. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.058438 · Cited by 91
Insulin Resistance in HIV-Patients: Causes and Consequences
Pedro, M. N., Rocha, G. Z., Guadagnini, D., Santos, A., Magro, D. O., Assalin, H. B., Oliveira, A. G., Pedro, R. D. J., & Saad, M. J. A. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00514 · Cited by 92
Matsumori, A. (2023) · European Cardiology Review · doi:10.15420/ecr.2023.10 · Cited by 95
Maternal obesity induces sustained inflammation in both fetal and offspring large intestine of sheep
Yan, X., Huang, Y., Wang, H., Du, ., Hess, B. W., Ford, S. P., Nathanielsz, P. W., & Zhu, M.-J. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21539 · Cited by 85
“NF-jB is an important downstream mediator of TLR2 and TLR4-induced inflammatory response.(43) In the quiescent state, NF-jB binds to IjB.”
BackgroundActivating Transcription Factor 3 Regulates Immune and Metabolic Homeostasis
Rynes, J., Donohoe, C. D., Frommolt, P., Brodesser, S., Jindra, M., & Uhlirova, M. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00429-12 · Cited by 80
Molecular imaging of the transcription factor NF-κB, a primary regulator of stress response
Carlsen, H., Alexander, G., Austenaa, L. M. I., Ebihara, K., & Blomhoff, R. (2004) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2004.02.024 · Cited by 82
Smith, B. K., Ford, R. J., Desjardins, E. M., Green, A. E., Hughes, M. C., Houde, V. P., Day, E. A., Marcinko, K., Crane, J. D., Mottillo, E. P., et al. (2016) · Diabetes · doi:10.2337/db16-0564 · Cited by 79
Lv, Z., Xing, K., Li, G., Liu, D., & Guo, Y. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01493 · Cited by 85
“Furthermore, increased plasma FFA levels can activate toll-like receptor 4 on the surface of macrophages and adipocytes, thereby inducing an inflammatory response in the fatty liver (Yuan, 2001).”
BackgroundNon-alcoholic fatty liver disease and insulin resistance
Machado, M., & Cortez-Pinto, H. (2005) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200508000-00008 · Cited by 79
Cleasby, M. E., Dzamko, N., Hegarty, B. D., Cooney, G. J., Kraegen, E. W., & Ye, J.-M. (2004) · Diabetes · doi:10.2337/diabetes.53.12.3258 · Cited by 79
Lee, M. S., Choi, S., Ha, E. S., An, S.-Y., Kim, T. H., Han, S. J., Kim, H. J., Kim, D. J., KANG, Y. Y., & Lee, K. W. (2012) · Metabolism · doi:10.1016/j.metabol.2012.01.012 · Cited by 87
Zhu, D., Wang, Y., Du, Q., Liu, Z., & Liu, X. (2015) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5b04533 · Cited by 82
Type 1 Diabetes Is Associated With Increased Cyclooxygenase- and Cytokine-Mediated Inflammation
Basu, S., Larsson, A. O., Vessby, J., Vessby, B. O., & Berne, C. (2005) · Diabetes Care · doi:10.2337/diacare.28.6.1371 · Cited by 84
“Recently, it has also been shown that high doses of salicylates specifically inhibit the function of I- -kinase- , a key protein involved in the regulation of inflammation that interferes with insulin signaling and contributes to both insulin resistance and diabetes (34).”
Green, C. J., Macrae, K., Fogarty, S., Hardie, D. G., Sakamoto, K., & Hundal, H. S. (2011) · Biochemical Journal · doi:10.1042/bj20101517 · Cited by 78
Genetic determinants and molecular pathways in the pathogenesis of Type 2 diabetes
Jin, W., & Patti, M.-E. (2009) · Clinical Science · doi:10.1042/cs20080090 · Cited by 78
Gupte, A. A., Bomhoff, G. L., Morris, J. K., Gorres, B. K., & Geiger, P. C. (2009) · Journal of Applied Physiology · doi:10.1152/japplphysiol.91210.2008 · Cited by 78
“Stress kinases, such as c-Jun NH2terminal kinase (JNK) and the inhibitor of B kinase(IKK ), are activated by oxidative stress, and activity levels of these kinases are high in skeletal muscles from insulin-resistant animals (14, 21, 40, 54).”
BackgroundIrudayaraj, S. S., Sunil, C., Stalin, A., Duraipandiyan, V., Abdullah, A.-D. N., & Savarimuthu Ignacimuthu, S. J. (2017) · Pharmaceutical Biology · doi:10.1080/13880209.2017.1279671 · Cited by 78
“Yuan et al. (2001) have suggested that hyperinsulinaemia caused by insulin resistance in peripheral tissues damages the structural integrity of b-cells.”
BackgroundKim, J.-A., Yeh, D. C., Ver, M., Li, Y., Carranza, A., Conrads, T. P., Veenstra, T. D., Harrington, M. A., & Quon, M. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501439200 · Cited by 78
Sharma, A. K., Bharti, S., Goyal, S. N., Arora, S., Nepal, S., Kishore, K., Joshi, S., Kumari, S., & Arya, D. S. (2011) · Phytotherapy Research · doi:10.1002/ptr.3442 · Cited by 77
“The HFD induced hypercholesterolemia and hypertriglyceridemia may result from increased absorption of TGs and cholesterol in the form of chylomicrons, raised endogenous very low density lipoproteins (VLDL) production, and/or alteration of their metabolism in diabetic states (Zammit et al., 2001).”
BackgroundVlavcheski, F., Hartogh, D. J. D., Giacca, A., & Tsiani, E. (2020) · Nutrients · doi:10.3390/nu12040914 · Cited by 259
Kuzu, N., Bahçecioğlu, İ. H., Dağlı, A. F., Özercan, İ. H., Üstündağ, B., & Şahin, K. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.05052.x · Cited by 83
Melo, A. M., Benatti, R. O., Ignácio-Souza, L. M., Okino, C., Torsoni, A. S., Milanski, M., Velloso, L. A., & Torsoni, M. A. (2014) · Metabolism · doi:10.1016/j.metabol.2014.02.002 · Cited by 86
“[24] Yuan M, Konstantopoulos N, Lee J, et al.”
BackgroundKang, S., Tsai, L. T., Zhou, Y., Evertts, A., Xu, S., Griffin, M. J., Issner, R., Whitton, H. J., Garcia, B. A., Epstein, C. B., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3080 · Cited by 77
Gene Expression Profiling of the PPAR-alpha Agonist Ciprofibrate in the Cynomolgus Monkey Liver
Cariello, N. F., Romach, E. H., Colton, H. M., Ni, H., Yoon, L., Falls, J. G., Casey, W., Creech, D., Anderson, S. P., Benavides, G. R., et al. (2005) · Toxicological Sciences · doi:10.1093/toxsci/kfi273 · Cited by 77
“IκB, a key regulator of NFκB, may be a key mediator in insulin resistance as was suggested by recent work demonstrating that high doses of salicylates, which inhibit IκB activation, reversed hyperglycemia, hyperinsulinemia, and dyslipidemia in obese rodents by sensitizing insulin signaling (Yuan et al. 2001).”
BackgroundLiu, M.-J., Bao, S., Bolin, E. R., Burris, D. L., Xu, X., Sun, Q., Killilea, D. W., Shen, Q., Ziouzenkova, O., Belury, M. A., et al. (2013) · Journal of Nutrition · doi:10.3945/jn.113.175158 · Cited by 87
“The inhibition of IKK and NF-kB has been proposed as the mechanism whereby antiinflammatory agents such as salicylates reverse insulin resistance (18,19).”
BackgroundLi, S., Wan, J., Anderson, W. H., Sun, H., Zhang, H., Peng, X., Yu, Z., Wang, T., Yan, X., & Smith, W. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.01.036 · Cited by 80
PPARγ as a therapeutic target in diabetic nephropathy and other renal diseases
Yang, J., Zhou, Y., & Guan, Y. (2011) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e32834de526 · Cited by 83
Priscilla, D. H., Jayakumar, M., & Thirumurugan, K. (2015) · Journal of Functional Foods · doi:10.1016/j.jff.2015.02.005 · Cited by 75
Jauregui, A. N., Mintz, D. H., Mundel, P. H., & Fornoni, A. (2009) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e32832f7002 · Cited by 82
Data‐Mining Analysis Suggests an Epigenetic Pathogenesis for Type 2 Diabetes
Wren, J. D., & Garner, H. R. (2005) · BioMed Research International · doi:10.1155/jbb.2005.104 · Cited by 76
Sleep‐Disordered Breathing and Obesity: Pathophysiology, Complications, and Treatment
Leinum, C. J., Dopp, J. M., & Morgan, B. J. (2009) · Nutrition in Clinical Practice · doi:10.1177/0884533609351532 · Cited by 76
Camm, E. J., Martin‐Gronert, M. S., Wright, N. L., Hansell, J. A., Ozanne, S. E., & Giussani, D. A. (2011) · The FASEB Journal · doi:10.1096/fj.10-158188 · Cited by 75
Bahçecioğlu, İ. H., Kuzu, N., Metin, K., Özercan, İ. H., Üstündağ, B., Şahin, K., & Küçük, Ö. (2010) · Veterinary Medicine International · doi:10.4061/2010/262179 · Cited by 80
“It leads to the activation of inhibitor kappa kinase beta (IKK-β), and thereby causes peripheral insulin resistance [39].”
BackgroundDevelopment of insulin resistance and reversal by thiazolidinediones in C2C12 skeletal muscle cells
Kumar, N., & Dey, C. S. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01509-5 · Cited by 80
Li, H., Li, H., Bao, Y., Zhang, X., & Yu, Y. (2010) · International Journal of Cardiology · doi:10.1016/j.ijcard.2010.07.019 · Cited by 86
Immunometabolism of AMPK in insulin resistance and atherosclerosis
Fullerton, M. D., Steinberg, G. R., & Schertzer, J. D. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.02.004 · Cited by 77
IKKβ suppression of TSC1 function links the mTOR pathway with insulin resistance
Hung (1998) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000065 · Cited by 75
IKKβ links vascular inflammation to obesity and atherosclerosis
Sui, Y., Park, S., Xu, J., Monette, S., Helsley, R. N., Han, S., & Zhou, C. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20131281 · Cited by 77
“Reid et al., 1957; Kim et al., 2001; Yuan et al., 2001).”
BackgroundInfluentialRole of oxidative stress in endothelial insulin resistance
Paneni, F., Costantino, S., & Cosentino, F. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i2.326 · Cited by 83
Solomon, T. P. J., Haus, J. M., Marchetti, C. M., Stanley, W. C., & Kirwan, J. P. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00220.2009 · Cited by 73
Kim, J. K., Kim, H.-J., Park, S.-Y., Cederberg, A., Westergren, R., Nilsson, D., Higashimori, T., Cho, Y.-R., Liu, Z.-X., Dong, J., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1657 · Cited by 74
“(31) have demonstrated that activation of IKK- resulted in defects in skeletal muscle insulin signaling, while our previous study (29) has shown that mice with heterozygous deletion of IKK- were protected from fat-induced insulin resistance in skeletal muscle.”
BackgroundBoonyasrisawat, W., Eberlé, D., Bacci, S., Zhang, Y.-Y., Nolan, D., Gervino, E. V., Johnstone, M. T., Trischitta, V., Shoelson, S. E., & Doria, A. (2007) · Diabetes · doi:10.2337/db06-0946 · Cited by 74
Self-citationPrada, P. O., Ropelle, E. R., Mourão, R. H. V., de Souza, C. T., Pauli, J. R., Cintra, D. E., Schenka, A. A., Rocco, S. A., Rittner, R., Franchini, K. G., et al. (2009) · Diabetes · doi:10.2337/db08-0506 · Cited by 80
RetractedHam, M., Choe, S. S., Shin, K. C., Choi, G., Kim, J., Noh, J., Kim, Y., Ryu, J.-W., Yoon, K., Lee, C., et al. (2016) · Diabetes · doi:10.2337/db16-0060 · Cited by 77
Acierno, C., Caturano, A., Pafundi, P. C., Nevola, R., Adinolfi, L. E., & Sasso, F. C. (2020) · Exploration of Medicine · doi:10.37349/emed.2020.00019 · Cited by 73
“In this case, IKK-β could be a potential therapeutic target for insulin sensitization [58].”
BackgroundCD24-Siglec axis is an innate immune checkpoint against metaflammation and metabolic disorder
Wang, X., Liu, M., Zhang, J., Brown, N. K., Zhang, P., Zhang, Y., Liu, H., Du, X., Wu, W., Devenport, M., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.07.005 · Cited by 74
Iyer, A., Kauter, K., Alam, M. A., Hwang, S. H., Morisseau, C. H. P., Hammock, B. D., & Brown, L. (2011) · Experimental Diabetes Research · doi:10.1155/2012/758614 · Cited by 80
“Pharmacological manipulation of the cyclooxygenase and lipoxygenase pathways improves adiposity and insulin sensitivity in humans and animal models [1, 14–16].”
Foods for the prevention of diabetes: how do they work?
Thomas, T., & Pfeiffer, A. F. H. (2012) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1229 · Cited by 73
Adipose stress-sensing kinases: linking obesity to malfunction
Rudich, A., Kanety, H., & Bashan, N. (2007) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2007.08.006 · Cited by 82
Mu, Y., Ogawa, T., & Kawada, N. (2009) · Laboratory Investigation · doi:10.1038/labinvest.2009.123 · Cited by 83
“14 Over the past decade, it has become clear that obesity is associated with the activation of cellular stress signaling and inflammatory pathways”
BackgroundAggravation by prostaglandin E2 of interleukin-6-dependent insulin resistance in hepatocytes #
Henkel, J., Neuschäfer-Rube, F., Pathe-Neuschäfer-Rube, A., & Püschel, G. P. (2009) · Hepatology · doi:10.1002/hep.23064 · Cited by 73
Diabetic Cardiomyopathy: An Immunometabolic Perspective
Mishra, P. K., Ying, W., Nandi, S. S., Bandyopadhyay, G. K., Patel, K. P., & Mahata, S. K. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00072 · Cited by 80
Liu, K., Zhao, W., Gao, X., Huang, F., Kou, J., & Liu, B. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.06.012 · Cited by 74
“It has beenwell established that IKKb activation modulates proinflammatory cytokine expression or production by the activation of NF-kB and plays a critical role in FFA-induced endothelial dysfunction [5,21,24].”
BackgroundResultMacrophage-targeted delivery systems for nucleic acid therapy of inflammatory diseases
Singh, A. K., Talekar, M., Raikar, A., & Amiji, M. M. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.04.021 · Cited by 77
“However, this approach did not only provide an antiinflammatory effect but helped to improve insulin sensitivity in vivo [136].”
BackgroundCarvalho-Filho, M. A., Carvalho, B. M., Oliveira, A. G., Guadagnini, D., Ueno, M., Dias, M. M., Tsukumo, D. M., Hirabara, S. M., Reis, L. F., Curi, R., et al. (2012) · Endocrinology · doi:10.1210/en.2012-1400 · Cited by 72
Functional genomic analysis unravels a metabolic-inflammatory interplay in adrenoleukodystrophy
Schlüter, A., Espinosa, L., Fourcade, S., Galino, J., López, E., Ilieva, E., Morató, L., Asheuer, M., Cook, T., McLaren, A., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/ddr536 · Cited by 72
“salicylates that inhibit IKKb (49) or treatment with adiponectin to block TLR pathways) will shed light on whether the early proinflammatory phase of X-ALD is neuroprotective or, in the contrary, contributes to axonopathy.”
BackgroundAdiponectin: a key fat-derived molecule regulating inflammation
Tilg, H., & Wolf, A. M. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.2.245 · Cited by 71
“showed that blocking inflammation with salicylates positively affects insulin resistance and targeting inhibitor of κB kinase-β, a downstream molecule regulating TNF and insulin signalling, improves insulin resistance [15].”
BackgroundBehl, T., Sharma, E., Sehgal, A., Kaur, I., Kumar, A., Arora, R., Pal, G., Kakkar, M., Kaundal, R. K., & BUNGAU, S. G. (2021) · Molecular Biology Reports · doi:10.1007/s11033-020-06130-x · Cited by 77
Brown Adipose Tissue Harbors a Distinct Sub-Population of Regulatory T Cells
Medrikova, D., Sijmonsma, T. P., Sowodniok, K., Richards, D. M., Delacher, M., Sticht, C., Gretz, N., Schafmeier, T., Feuerer, M., & Herzig, S. (2015) · PLOS ONE · doi:10.1371/journal.pone.0118534 · Cited by 70
“Consequently, anti-inflammatory treatment potently improves insulin sensitivity in obesity [5].”
BackgroundMolecular mechanisms of insulin resistance in chronic hepatitis C
Douglas, M. W., & George, J. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.4356 · Cited by 81
Metadata
- Authors
- Yuan, M., Konstantopoulos, N., Lee, J., Hansen, L., Li, Z.-W., Karin, M., & Shoelson, S. E.
- Affiliations
- Joslin Diabetes Center (US)
- Department of Pharmacology, University of California, San Diego, La Jolla, CA 92093, USA.
- University of California San Diego (US)
- Corresponding author
- Yuan, Minsheng
- Konstantopoulos, Nicky
- Lee, Jongsoon
- Shoelson, Steven E.
- Venue
- Science
- Published
- 2001-08-31
- Volume
- 293
- Issue
- 5535
- Pages
- 1673-1677
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2031637294
- Cited by
- 1,884
- References
- 26
- Citations by year
- 2026: 16 · 2025: 29 · 2024: 27 · 2023: 36 · 2022: 41 · 2021: 51 · 2020: 51 · 2019: 61 · 2018: 54 · 2017: 70 · 2016: 78 · 2015: 93 · 2014: 109 · 2013: 124 · 2012: 99
- FWCI
- 56.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r29dk045493-05)
- National Institute of Allergy and Infectious Diseases (AI 43477)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 51729, DK45493)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- insulin resistance, obesity, salicylates, IκB kinase β, insulin signaling, inflammation, type 2 diabetes, hyperinsulinemia, hyperglycemia, dyslipidemia, high-fat diet, ob/ob mice, insulin sensitization, cyclooxygenase
- MeSH terms
- Animals, Anti-Inflammatory Agents, Non-Steroidal, Aspirin, Blood Glucose, Cell Line, Dietary Fats, Glucose Tolerance Test, Insulin, Insulin Resistance, Lipids, Liver, Male, Mice, Obese, Muscles, Obesity, Phosphorylation, Prostaglandin-Endoperoxide Synthases, Rats, Zucker, Receptor, Insulin, Sodium Salicylate, Tumor Necrosis Factor-alpha, Signal Transduction, Protein Serine-Threonine Kinases, Gene Deletion, Gene Targeting, Mice, Rats, I-kappa B Kinase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.